drugset / Trial / NCT00040053
Ondansetron for the Treatment of Methamphetamine Dependence - 1
RandomizedDouble-blindTreatment
Summary
The purpose of this study is to assess ondansetron for the treatment of methamphetamine dependence.
Timeline
- Start
- 2002-06
- Primary completion
- —
- Completion
- 2004-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ondansetron | Other / unclassified | 0.25 mg | Oral |
| Subject | Ondansetron | Other / unclassified | 1 mg | Oral |
| Subject | Ondansetron | Other / unclassified | 4 mg | Oral |